Literature DB >> 8119421

Visual prognosis following accidental vitreous loss during cataract surgery.

C Claoué1, A Steele.   

Abstract

Over the past 7 years there has been a change in the management of accidental vitreous loss during cataract surgery. There has been a reduction in immediate postoperative complications such as hyphaema. No immediate post-operative complications were observed during the last 18 months of the study. Whereas previously many of these patients remained aphakic, there was a change initially to anterior chamber intraocular lenses (IOLs) and now the vast majority receive capsule-supported sulcus-fixated posterior chamber IOLs. All patients had improved vision post-operatively by a mean of 4 Snellen lines, although they did not achieve the acuities of age- and sex-matched controls (p = 0.015).

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8119421     DOI: 10.1038/eye.1993.171

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  4 in total

1.  Complication rate and risk factors for intraoperative complications in resident-performed phacoemulsification surgery.

Authors:  Andrea Briszi; Philipp Prahs; Jost Hillenkamp; Horst Helbig; Wolfgang Herrmann
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-04-11       Impact factor: 3.117

2.  Risk factors for vitreous complications in resident-performed phacoemulsification surgery.

Authors:  Preston H Blomquist; Marlene E Morales; Liyue Tong; Chul Ahn
Journal:  J Cataract Refract Surg       Date:  2011-11-21       Impact factor: 3.351

3.  Effects of posterior capsular disruption on the outcome of phacoemulsification surgery.

Authors:  M Mulhern; G Kelly; P Barry
Journal:  Br J Ophthalmol       Date:  1995-12       Impact factor: 4.638

4.  Outcomes and favourable prognostic factors in patients of phacomorphic and phacolytic glaucoma managed by manual small-incision cataract surgery: A retrospective study.

Authors:  Shivkumar Chandrashekharan; Sabyasachi Chakrabarty; Meghana Tanwar; Bharadwaja Madhuvarasu; Mohammed Sithiq Uduman; Rengappa Ramakrishnan
Journal:  Indian J Ophthalmol       Date:  2022-04       Impact factor: 2.969

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.